New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols
Berardi, R.; Verdecchia, L.; Scartozzi, M.; Cascinu, S.
Jop Journal of the Pancreas 6(1 Suppl): 118-121
2005
ISSN/ISBN: 1590-8577 PMID: 15650296 Document Number: 588570
Document emailed within 1 workday
Related Documents
Berger, A.C.; Watson, J.C.; Ross, E.A.; Zalatoris, A.; Hoffman, J.P. 2004: Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma American Surgeon 70(2): 169-173; Discussion: 173-174Andros, E.A.; Danesghari, F.; Crawford, E.D. 1993: Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate Clinical and Investigative Medicine. Medecine Clinique et Experimentale 16(6): 510-515
Philip, P.A. 2011: Are we ready for neoadjuvant therapy in potentially resectable pancreatic cancer? Oncology 25(2): 189-190; 192
Mataki, Y.; Shinchi, H.; Maemura, K.; Kurahara, H.; Kawasaki, Y.; Desaki, R.; Ueno, S.; Sakoda, M.; Iino, S.; Higashi, M.; Takao, S.; Natsugoe, S. 2013: Examination of resectable and borderline pancreatic cancer treated with neoadjuvant chemoradiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1637-1640
2015: (S021) the role of neoadjuvant stereotactic body radiation therapy in pancreatic cancer Oncology 29(4 Suppl. 1)
Aziz, H.; Zeeshan, M.; Jie, T.; Maegawa, F.B. 2019: Neoadjuvant Chemoradiation Therapy Is Associated with Adverse Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer American Surgeon 85(11): 1276-1280
Tepel, J.; March, C.; Ketterer, T.; Kapischke, M.; Arlt, A.; Kremer, B.; Kalthoff, H.; Kruse, M-Luise. 2006: A modified random oligonucleotide-based combination therapy for adjuvant treatment of pancreatic ductal adenocarcinoma International Journal of Oncology 28(5): 1105-1112
Yin, S.; Goodrich, D.W. 2006: Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma International Journal of Oncology 28(3): 781-785
Tada, M.; Omata, M.; Kawai, S.; Saisho, H.; Ohto, M.; Saiki, R.K.; Sninsky, J.J. 1993: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma Cancer Research 53(11): 2472-2474
Shiba, H.; Misawa, T.; Fujiwara, Y.; Futagawa, Y.; Furukawa, K.; Haruki, K.; Iida, T.; Iwase, R.; Yanaga, K. 2013: Negative impact of fresh-frozen plasma transfusion on prognosis of pancreatic ductal adenocarcinoma after pancreatic resection Anticancer Research 33(9): 4041-4047
Alexander, H.R.; Grem, J.L.; Pass, H.I.; Hamilton, M.; McAtee, N.; Fraker, D.L.; Allegra, C.J. 1993: Neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma Oncology 7(5): 37-42; Discussion: 42-44; 49-50, 53
Lygidakis, N.J.; Dedemati, G.; Spenzaris, N.; Theodoropoulou, M. 1997: Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative? Hepato-Gastroenterology 44(16): 1222-1228
Ochiai, T.; Inoue, H.; Nakatsuji, H.; Watanabe, N.; Yoshiyama, A.; Ito, H.; Toma, A.; Nakamura, K. 2017: Neoadjuvant FOLFIRINOX for Unresectable Adenocarcinoma of the Pancreas - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1349-1351
Montrone, S.; Gonnelli, A.; Cantarella, M.; Sainato, A. 2015: Use of Proktis-M suppositories in patients undergoing neoadjuvant radiochemotherapy for adenocarcinoma of the rectum Minerva Gastroenterologica e Dietologica 61(4): 293-297
Motoi, F.; Kawaguchi, K.; Aoki, T.; Kudo, K.; Yabuuchi, S.; Fukase, K.; Mizuma, M.; Sakata, N.; Otsutomo, S.; Morikawa, T.; Hayashi, H.; Nakagawa, K.; Okada, T.; Yoshida, H.; Naitoh, T.; Katayose, Y.; Egawa, S.; Unno, M. 2013: Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1632-1636
MacNeill, T 2011: New Frontiers of Social Policy: Inclusive States: Social Policy and Structural Inequalities New Frontiers of Social Policy: Assets, Livelihoods, and Social Policy New Frontiers of Social Policy: Institutional Paths to Equity: Addressing Inequality Traps Review of Social Economy 69(2): 261-270
Ji, Y.; Peng, T.; Wang, G.; Zhang, Y.; Cao, M.; Gao, Q.; Li, S. 2018: Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage IIi adenocarcinoma of esophagogastric junction Zhonghua Wei Chang Wai Ke Za Zhi 21(9): 1019-1024
Puduvalli, V.K.; Yung, A.W. 1998: New frontiers in therapy of malignant gliomas Forum 8(3): 261-269
Eggermont, A.M. 2001: Frontiers in adjuvant therapy in stage II-IIi melanoma Tumori 87(4): S60-S63
Watanabe, F.; Honda, G.; Kurata, M.; Tsuruta, K.; Tokashiki, T.; Funada, N. 2009: A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2430-2432